Physician profile
Leonard Liang
NPI 1134131196
$16,066.23
in general payments reported to CMS, 2019-2025
25 companies · $971 in 2025
The $971 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $240 · 2021: $449 · 2022: $12K · 2023: $692 · 2024: $1,264 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,638 · Travel and Lodging: $180 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,637.72 |
| Travel and Lodging | $180.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,124.66 | 2022 | |
| Pfizer INC. | $1,221.39 | 2019-2025 | |
| Astellas Pharma US INC | $576.86 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $574.96 | 2024 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $429.72 | 2021-2024 | Prolaris |
| Teleflex LLC | $392.35 | 2024-2025 | Urolift, Solesta |
| Dendreon Pharmaceuticals LLC | $375.15 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $260.91 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $207.79 | 2023-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $155.53 | 2022-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $122.66 | 2021-2024 | Xiaflex |
| Comsort, INC | $100.00 | 2019 | |
| Agiliti Surgical, INC. | $93.81 | 2022-2023 | Sonablate |
| Coloplast Corp | $70.03 | 2021-2022 | |
| Boston Scientific Corporation | $59.49 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $56.51 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $39.52 | 2022-2023 | Lynparza |
| Merck Sharp & Dohme LLC | $32.35 | 2025 | Keytruda |
| Abiomed | $29.26 | 2021 | |
| 180 Medical, INC. | $28.14 | 2020 | |
| Koelis INC. | $26.58 | 2023 | |
| Olympus America INC. | $26.55 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $24.05 | 2023 | Bard Urinary Drainage Bag |
| Balt USA, LLC | $21.30 | 2024 | Prestige Coil System |
| Takeda Pharmaceuticals U.S.A., INC. | $16.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.